Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Living Cell Technologies
LCT - Living Cell Technologies

News

News updates: Subscribe
Unsubscribe

Archive

June 5, 2008
LCT Expands Diabetes Clinical Trial
>more
June 3, 2008
LCT Lists on International OTCQX
>more
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
>video
May 12, 2008
LCT presents encapsulation technology at conference
>more
May 8, 2008
LCT features on Channel Ten News
>more
>video
May 8, 2008
LCT prepares to list on international OTCQX
>more
 

News

LCT Investor Update - March 2007
March 5, 2007

This monthly update is to help explain the current business and research activities undertaken by Living Cell Technologies and the progression of its lead products to market. In this edition, it includes:

  • Results of the share purchase plan
  • Half-year financial report results
  • Product development update

    • Related Document
    Download ( = 139Kb )

    LCT - Living Cell Technologies

    Q & A

    What is xenotransplantation?
    The use of living animal cells, tissues or organs in human therapeutics. >more

    What is DiabeCell?
    DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

    What is NeurotrophinCell?
    A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

    What is LCT's encapsulation technology?
    The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
    need for toxic immunosuppressant drugs and allow the release of beneficial factors.     >more
     
    HomeContactSitemapLegalsPrivacy
    		  
    graphic design and website design - PDF Communications Ltd